Naheed Kurji

@NaheedKurji

CEO of Cyclica. Passionate Entrepreneur. Ambitious Change Agent. Global Tourist. Sports Enthusiast.

Toronto, Ontario
Vrijeme pridruživanja: listopad 2011.

Tweetovi

Blokirali ste korisnika/cu @NaheedKurji

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NaheedKurji

  1. 29. sij

    At we've partnered with Atai Life Sciences to form Entheogenix Biosciences a joint venture that is bringing an avant-garde strategy around psilocybin and other psychedelics to address mental health and neuropsychiatric diseases.

    Poništi
  2. 29. sij

    Taking care of ones is as important as taking care of any other health challenge. I’ve gone through my own, and it’s because of the people around me, their willingness to listen, and the unrelenting support that I was able to overcome it.

    Poništi
  3. proslijedio/la je Tweet

    Today is Day! Every year, Bell donates 5¢ to Canadian mental health initiatives for every retweet. Last year, we had 25K retweets. Let’s beat that!

    Poništi
  4. proslijedio/la je Tweet
    10. stu 2019.

    This could be the future of shrooms and other psychedelics.

    Poništi
  5. proslijedio/la je Tweet
    12. pro 2019.

    New technologies continue to pave the path for transformations. This week our CEO, was featured in the on the impact of and opportunities for AI to provide insights on a medicine's potential effect.

    Poništi
  6. proslijedio/la je Tweet
    2. sij

    "Emerging and innovative biotechs will decentralize the pipeline." Our CEO, discusses the future of and to bring new medicines through the clinic in our most recent feature in the . Read more here:

    Poništi
  7. proslijedio/la je Tweet
    6. sij

    Today, we are excited to announce the latest addition to our leadership team. Former Director of Applications Science at , Melissa Landon joins Cyclica as VP, Chief Strategist. Read the press release here:

    Poništi
  8. proslijedio/la je Tweet
    10. pro 2019.

    Just b/c Big Pharma externally sources >50% of their new programs doesn't mean they aren't investing in innovation.. R&D is team sport. W/o them as downstream partners for young biotechs, we'd b unable 2 advance drugs to mkt. They r essential players in the innovation ecosystem

    Poništi
  9. 9. lis 2019.

    To build stronger partnerships globally, Cyclica appoints long time pharma R&D leader Vern De Biasi as VP, Global Head of Strategic Partnerships

    Poništi
  10. proslijedio/la je Tweet
    4. lis 2019.
    Poništi
  11. proslijedio/la je Tweet
    26. ruj 2019.

    Exscientia called as 1 of the few firms using tech to design multi-targeted drugs in a great piece by for : . We agree that the "1 target, 1 drug" paradigm is no longer fit for purpose for an industry lagging behind in productivity

    Poništi
  12. proslijedio/la je Tweet

    You know what isn't a crucial overall step in drug discovery? Not yet, anyway? Protein structure, as much as it pains me to say that:

    Poništi
  13. 17. ruj 2019.

    Designing a highly potent molecule for one target can be limited. What about off-targets, ADME, etc? For many diseases the master key are multi targeted drugs that are designed to be drug like, synthetically accessible, and with PK in mind.

    Poništi
  14. proslijedio/la je Tweet

    Thought leadership from CEO on bridging biology, chemistry & computation to design the best medicines:

    Poništi
  15. proslijedio/la je Tweet

    Join in Boston for the Summit Oct 9 where he'll share 's story & some exciting updates.

    Poništi
  16. proslijedio/la je Tweet

    Bridging Biology, Chemistry And Computation To Design The Best Medicines via

    Poništi
  17. proslijedio/la je Tweet
    29. kol 2019.
    Poništi
  18. proslijedio/la je Tweet

    🔬 is changing the game of drug discovery. His company 's platform analyzes molecules to help scientists design, screen + personalize medicines.

    Poništi
  19. proslijedio/la je Tweet
    25. srp 2019.

    Love seeing two companies collaborate to advance healthcare! Congratulations to and Rosetta!

    Poništi
  20. proslijedio/la je Tweet

    ’s & biotechnology company have launched a partnership to advance treatment of drug-resistant lung cancer

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·